15 results
8-K
EX-99.1
VERV
Verve Therapeutics Inc
10 Nov 21
Verve Therapeutics Announces Pipeline Progress and Reports Third Quarter 2021 Financial Results
6:56am
medicines. Backed by an expert team and a strong balance sheet, we stand well positioned to advance our gene editing therapies and fundamentally change
S-1
EX-10.11
mrguk08ygwk2rh d9833
28 May 21
IPO registration
4:04pm
S-1
EX-10.12
4dgdr0u9v7uyaegbox7b
28 May 21
IPO registration
4:04pm
S-1
EX-10.9
jhsi1x 3vjxq6
28 May 21
IPO registration
4:04pm
S-1
EX-10.17
41hr8eznl8w l4wxtwyv
28 May 21
IPO registration
4:04pm
S-1
EX-10.13
nudcb1bl
28 May 21
IPO registration
4:04pm
DRS
vvobenyz
16 Apr 21
Draft registration statement
12:00am
DRS
EX-10.10
nk5yqgc
16 Apr 21
Draft registration statement
12:00am
DRS
EX-10.13
13ck8odbflaheuecuxh
16 Apr 21
Draft registration statement
12:00am
DRS
EX-10.12
obj6veipm
16 Apr 21
Draft registration statement
12:00am
DRS
EX-10.14
53tkrs5t3rq20z1
16 Apr 21
Draft registration statement
12:00am
- Prev
- 1
- Next